Abrupt formation of intracardiac thrombus during cardiopulmonary bypass with full heparinization -A case report- by Kim, Seong-Hyop et al.
Korean J Anesthesiol 2012 February 62(2): 175-178 
http://dx.doi.org/10.4097/kjae.2012.62.2.175  Case Report
Intracardiac thrombus during cardiopulmonary bypass (CPB) with full heparinization is very rare but fatal. A 
60-year-old woman was scheduled for aortic and mitral valve repairs with a maze procedure for mixed aortic and 
mitral valvular heart disease with atrial fibrillation. Preoperative transthoracic echocardiography and cardiac 
computed tomography showed moderate aortic regurgitation and moderate mitral stenosis with regurgitation. There 
was no intracardiac thrombus. Aortic and mitral valve repairs with the maze procedure were successfully performed 
without unexpected events. During CPB weaning, a mobile hyper-echogenic mass in the left atrium was detected on 
transesophageal echocardiography. After cardiac arrest, it was surgically removed. On completion of the operation, 
weaning from CPB was accomplished uneventfully. The patient fully recovered and was discharged from the 
intensive care unit on her third postoperative day. (Korean J Anesthesiol 2012; 62: 175-178)
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Intracardiac thrombus during cardiopulmonary bypass 
(CPB) with full heparinization is rare but can be associated with 
serious complications because of its potential propagation in 
the direction of blood flow. The arterial embolism may lead to 
permanent damages, resulting in stroke, infarction of organs, or 
gangrene of extremities, commonly the lower extremities.
The diagnosis of intracardiac thrombus is difficult with 
clinical symptoms and signs while the patient is under general 
anesthesia. There is no definite way to diagnose intracardiac 
thrombus intraoperatively without transesophageal 
echocardiography (TEE).
Here we report a case of intracardiac thrombus that occurred 
during CPB with full heparinization in a patient undergoing 
aortic and mitral valve repairs with the maze procedure. 
We quickly diagnosed intracardiac thrombus with TEE and 
prevented the complications associated with it.
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A 60-year-old woman (height, 150 cm; weight, 58 kg) 
was scheduled for aortic and mitral valve repairs with maze 
procedure for mixed aortic and mitral valvular heart disease 
with atrial fibrillation (AF). She had taken digoxin, furosemide, 
atenolol, and warfarin for 6 months. Warfarin was stopped 
for 5 days before surgery. The preoperative electrocardiogram 
showed AF with ventricular rates of 60-100/min and left 
ventricular hypertrophy. Chest X-ray showed cardiomegaly 
and pleural effusion. Transthoracic echocardiography (TTE) 
and cardiac computed tomography (CT) revealed an ejection 
fraction of normal range and a dilated left atrium (LA) and 
ventricle, as well as moderate aortic regurgitation and moderate 
mitral stenosis and regurgitation. There was no intracardiac 
thrombus. Before the operation, coagulation profiles were as 
follows: prothrombin time (PT) 14.9 s, international normalized 
ratio (INR) 1.14, activated partial thromboplastin time (aPTT) 
35.2 s, and fibrinogen 255 mg/dl.
Upon arrival at the operation room, after establishing routine 
invasive arterial blood pressure and noninvasive patient moni-
toring (electrocardiography, pulse oximetry, bispectral index, 
and cerebral oximetry), anesthesia was induced and main-
tained using target-controlled infusion of propofol (target 
concentration, 1.2-1.3 μg/ml) and remifentanil (target 
concentration, 10-20 ng/ml). Muscle relaxation was achieved 
with the administration of a bolus of rocuronium under 
the guidance of peripheral monitoring of neuromuscular 
transmission. Then a pulmonary artery catheter (Swan-Ganz 
CCOmbo CCO/SvO2
Ⓡ, Edwards Lifesciences, Irvine, CA, 
USA) was inserted after anesthesia induction. TEE probe (6T 
probe
TM, GE Healthcare, Waukesha, WI, USA) was inserted. TEE 
(Vivid 7
TM, GE Healthcare, Waukesha, WI, USA) revealed no 
intracardiac thrombus, as was seen in the preoperative TTE and 
cardiac CT.
The activated clotting time (ACT) before CPB was 140 s. CPB 
was initiated after heparin 300 units/kg was injected, and ACT 
above 450 s was achieved. During CPB for 211 min, the ACT 
was checked every 60 min and maintained above 450 s with 
additional heparin 2,000 units given 60 min after CPB started. 
Aortic and mitral valve repairs using bovine pericardium, a 
mitracon strip (Mitr-lift, Sciencity, Wonju-Shi, Kangwon-do, 
Korea), and a sinotubular junction ring, and following the maze 
procedure, were successfully performed without unexpected 
events. Defibrillation with 50 J was applied and TEE was 
performed to evaluate aortic and mitral valve and regional 
wall motion abnormality. There were no specific findings, 
including no thrombosis. The core temperature reached 36
oC 
and weaning of CPB was attempted. At that time, a mobile 
hyper-echogenic mass in the LA was detected via TEE (Fig. 1). 
The mass seemed to be a thrombus. It had a distinct border and 
different echogenic density than that of blood or the atrial wall. 
Its movement was separate from that of the atrial wall. At that 
point, the ACT was checked and recorded at 504 s. Rotation 
thromboelastometry (ROTEM
Ⓡ, TEM Innovations, Munich, 
Bayern, Germany) showed hypocoagulability, with clotting time 
(CT) of 972 sec (normal 100-240 sec), clot formation time (CFT) 
of 330 sec (normal 30-110 sec), α-angle 33.5
o (normal 70-83
o), 
and maximum clot firmness (MCF) of 49.8 mm (normal 50-
72 mm). After discussions with the cardiac surgeons, CPB was 
re-started for surgical confirmation and proper management 
of a mobile hyper-echogenic mass. Left atriotomy revealed that 
the mass was a thrombus, 15 × 20 mm in size with an irregular 
spherical surface (Fig. 2).
The second CPB weaning was successful. Protamine was 
injected for neutralization of heparin and an ACT of 124 s was 
Fig. 1. The mid-esophageal four-chamber view. The hyper-echogenic 
mass in the left atrium is shown. Fig. 2. The surgically removed intracardiac thrombus.177 www.ekja.org
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recorded. Total CPB time was 246 min. During CPB, three 
units of packed red blood cells (RBCs) were transfused. After 
weaning from CPB, eight units of platelet concentrates, three 
units of fresh frozen plasma (FFP), and three units of RBCs were 
transfused. On completion of the operation, weaning from CPB 
was accomplished uneventfully. The patient was transferred 
to the intensive care unit (ICU). In the ICU, mild coagulopathy 
was observed with PT 18.1 s, INR 1.46, aPTT 35.2 s, fibrinogen 
189 mg/dl, D-dimer 5.40 mcg/ml, and platelets 72000/mcl. 
After 3 days, the patient made an uneventful recovery and was 
transferred to a general ward.
Discussion
Intracardiac thrombus during or just after CPB have rarely 
been reported. In one such rare case, Gillham and Tousignant 
[1] reported severe acute thrombosis of a mechanical aortic 
valve prosthesis while the patient was fully heparinized on 
CPB. Multiple interacting prothrombotic factors, such as use of 
aprotinin [2-4], acquired antithrombin III deficiency, prolonged 
duration of CPB [5], post-protamine status [4], transfusion of 
blood components, disseminated intravascular coagulation [6], 
preoperative congestive heart failure [2], biological glue [1], and 
multiple prosthetic surfaces [5], may contribute to intracardiac 
thrombus during or just after CPB. The report by Gillham and 
Tousignant [1] was associated with the use of biological glue. In 
addition, the patient was resistant to heparin and an antifibri-
nolytic drug was also administered.
In our case, aprotinin was not administered, nor were 
any anti  fibrinolytic drugs, and the patient had no known 
coagulation disorders. Contrary to our expectations, the 
rotation thromboelastometry showed hypocoagulability. No 
blood components, except RBCs, were transfused before CPB 
weaning. Biological glue for aortic and mitral valve repairs 
was not used. Therefore, the prolonged duration of CPB (211 
min) might have contributed to the intracardiac thrombus 
in this case. Congested pulmonary venous blood, related to 
mitral regurgitation, might become sticky during an extended 
CPB. The patient had no right-to-left cardiac shunt, such as a 
patent foramen ovale. Preoperative examinations did not show 
intracardiac thrombus. Therefore, the intracardiac thrombus 
would have originated from the left cardiac chamber itself or 
the pulmonary veins.
Sudden development of refractory hypotension with a rapid 
rise in pulmonary artery pressures within 10 min after infusion 
of protamine and while closing the sternum might be key 
signs of right heart thrombus [6]. However, left heart thrombus 
cannot be detected until serious complication occurs.
Transesophageal echocardiography is a useful tool for 
the diagnosis and evaluation of intracardiac thrombus. In 
particular, the evaluation of posterior structures of the heart, 
such as the LA and left atrial appendage (LAA), is much easier 
with TEE. The sensitivity and specificity of TEE for thrombus 
in the LA have been reported as 93-100% and 99-100% [7-9], 
respectively.
However, it is important to distinguish between intracardiac 
thrombus and artifacts or pitfalls during TEE examination. Kim 
et al. [10] reported that folding of the right atrium appeared as a 
mass-like thrombus via TEE. Pressman and Figueredo [11] also 
reported misdiagnosis of the inverted LAA as an LA thrombus. A 
large hypertrophic trabecula [12], stagnant blood, or a warfarin 
ridge can also be confused for an intracardiac thrombus. In our 
case, however, the mobile hyper-echogenic mass with a clear-
cut margin was determined conclusively to be a thrombus. 
The mass was separate from the adjacent LA wall, so it could 
be distinguished from pectinate muscle, trabeculations, and 
inverted LAA. It could be differentiated from suture materials 
because it had no connection with the ring of the mitral valve 
annuloplasty and was less echogenic than suture materials.
In conclusion, abrupt formation of intracardiac thrombus 
with full heparinization can occur. For early detection of 
an intracardiac thrombus and prevention of detrimental 
outcomes, meticulous attention and close observation with TEE 
is required.
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